Difference between revisions of "Secretory carcinoma of the breast"

From Libre Pathology
Jump to navigation Jump to search
 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      =
| Width      =
| Caption    =
| Synonyms  =
| Micro      =
| Subtypes  =
| LMDDx      = [[lactational change]]
| Stains    =
| IHC        = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve
| EM        =
| Molecular  = ETV6-[[NTRK3]]
| IF        =
| Gross      =
| Grossing  = [[breast grossing]]
| Staging    = [[breast cancer staging]]
| Site      = [[breast]] - see ''[[invasive breast cancer]]''
| Assdx      =
| Syndromes  =
| Clinicalhx =
| Signs      =
| Symptoms  =
| Prevalence = rare
| Bloodwork  =
| Rads      =
| Endoscopy  =
| Prognosis  = favourable
| Other      =
| ClinDDx    =
| Tx        =
}}
'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with lactational changes]]''.
'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with lactational changes]]''.


Line 32: Line 64:
Characteristic translocation:<ref name=pmid22129193/>
Characteristic translocation:<ref name=pmid22129193/>
*t(12;15).  
*t(12;15).  
**ETV6-NTRK3.
**ETV6-[[NTRK3]].


Note:
Note:
*This translocation is also seen in [[mammary analogue secretory carcinoma]]<ref name=pmid20410810>{{Cite journal  | last1 = Skálová | first1 = A. | last2 = Vanecek | first2 = T. | last3 = Sima | first3 = R. | last4 = Laco | first4 = J. | last5 = Weinreb | first5 = I. | last6 = Perez-Ordonez | first6 = B. | last7 = Starek | first7 = I. | last8 = Geierova | first8 = M. | last9 = Simpson | first9 = RH. | title = Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. | journal = Am J Surg Pathol | volume = 34 | issue = 5 | pages = 599-608 | month = May | year = 2010 | doi = 10.1097/PAS.0b013e3181d9efcc | PMID = 20410810 }}</ref> and [[congenital-infantile fibrosarcoma]].
*This translocation is also seen in [[mammary analogue secretory carcinoma]],<ref name=pmid20410810>{{Cite journal  | last1 = Skálová | first1 = A. | last2 = Vanecek | first2 = T. | last3 = Sima | first3 = R. | last4 = Laco | first4 = J. | last5 = Weinreb | first5 = I. | last6 = Perez-Ordonez | first6 = B. | last7 = Starek | first7 = I. | last8 = Geierova | first8 = M. | last9 = Simpson | first9 = RH. | title = Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. | journal = Am J Surg Pathol | volume = 34 | issue = 5 | pages = 599-608 | month = May | year = 2010 | doi = 10.1097/PAS.0b013e3181d9efcc | PMID = 20410810 }}</ref> [[congenital-infantile fibrosarcoma]] and [[mesoblastic nephroma]].


==See also==
==See also==
*[[Invasive breast cancer]].
*[[Invasive breast cancer]].
*[[Secretory carcinoma of the salivary gland]] (previously known as ''mammary analogue secretory carcinoma'').
*[[Congenital-infantile fibrosarcoma]].


==References==
==References==

Latest revision as of 15:16, 31 December 2019

Secretory carcinoma of the breast is an uncommon form of invasive breast cancer that has an appearance similar to breast with lactational changes.

Secretory carcinoma of the breast
Diagnosis in short
LM DDx lactational change
IHC ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve
Molecular ETV6-NTRK3
Grossing notes breast grossing
Staging breast cancer staging
Site breast - see invasive breast cancer
Prevalence rare
Prognosis favourable

It is also known as secretory breast carcinoma (abbreviated SBC) and breast secretory carcinoma.

General

  • Favourable prognosis.[1]
  • Children and adults.

Microscopic

Features:[2]

  • Abundant cytoplasm with fine vacuolation - clear/pale or amphophilic.
  • Mitoses - uncommon.
  • Nucleoli - rare.
  • Architecture: solid, papillary, cribriform or microcystic.

DDx:

Images

IHC

Triple negative (ER -ve, PR -ve, HER2 -ve).[1]

Others:

  • Alpha-lactalbumin +ve.
  • S-100 protein +ve.
  • Polyclonal CEA +ve.

Molecular pathology

Characteristic translocation:[1]

Note:

See also

References

  1. ↑ 1.0 1.1 1.2 Vasudev, P.; Onuma, K. (Dec 2011). "Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.". Arch Pathol Lab Med 135 (12): 1606-10. doi:10.5858/arpa.2010-0351-RS. PMID 22129193.
  2. ↑ Laé, M.; Fréneaux, P.; Sastre-Garau, X.; Chouchane, O.; Sigal-Zafrani, B.; Vincent-Salomon, A. (Feb 2009). "Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.". Mod Pathol 22 (2): 291-8. doi:10.1038/modpathol.2008.184. PMID 19011601.
  3. ↑ Vesoulis, Z.; Kashkari, S.. "Fine needle aspiration of secretory breast carcinoma resembling lactational changes. A case report.". Acta Cytol 42 (4): 1032-6. PMID 9684599.
  4. ↑ Skálová, A.; Vanecek, T.; Sima, R.; Laco, J.; Weinreb, I.; Perez-Ordonez, B.; Starek, I.; Geierova, M. et al. (May 2010). "Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.". Am J Surg Pathol 34 (5): 599-608. doi:10.1097/PAS.0b013e3181d9efcc. PMID 20410810.
Retrieved from "https://librepathology.org/w/index.php?title=Secretory_carcinoma_of_the_breast&oldid=50614"